Pfizer Animal Health has agreed to purchase Embrex, an agricultural biotechnology company, in a stock deal valued at $155 million. Embrex' lead product, Inovoject, is a technology to deliver poultry ...

Pfizer Animal Health's Embrex Inovoject m is designed for hatcheries that do not have a large enough throughput to justify installation of the full-size Embrex Inovoject vaccination. Inovoject m is a ...

We’re keeping our finger on the pulse and bring you a summary of the latest business updates from the global poultry industry this March. CP Foods to achieve 20 million cage-free eggs in 2022 Charoen ...

MAXTON — The world’s largest animal health company, Zoetis, is selling a poultry vaccine and the Maxton plant that makes it, to Huvepharma, an animal health company based in Bulgaria. Employees at the ...

Visitors to poultry exhibitions and congresses around the world have been showing increasing interest in in ovo BioDevices as a means of increasing the efficiency of their operations. However, the ...

Pfizer Animal Health Global Poultry has launched a new, compact in ovo device aimed at vaccine manufacturers and research institutes. Embrex® Vaccine Manual Inovoject® (VMI) is the latest addition to ...

Embrex Inovoject m is an in ovo vaccination system designed for those poultry hatcheries that do not have a large enough footprint or throughput to justify the installation of a full-size Inovoject.